CMA Congressional Stock Trades
Comerica Inc (CMA)
Last disclosed trade Oct 6
Every disclosed trade in CMA by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.
Sample · the intelligence layer
Byron Donalds · Bought $CMA · May 3 · $1K–$15K
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow $CMA
Get notified when any member of Congress trades $CMA. Free, no card, no spam.
The record on $CMA
Coldpine has parsed 8 disclosed trades in $CMA by 2 members of Congress, drawn from 4 periodic transaction reports dated May 3, 2022 through Oct 6, 2025. All of them came from House members, filed 4 by Democrats and 4 by Republicans.
Of the 8 trades with a known filing lag, 4 were reported more than 45 days after the trade date, outside the window the STOCK Act sets. The median lag was 367 days. The longest was 920 days: a $CMA purchase by Byron Donalds dated May 3, 2022, disclosed Nov 8, 2024. How late filing is measured across all of Congress is in the late-filers study.
5 of the 8 trades that list an account holder (63%) were reported under a spouse, dependent child, or joint account rather than the member directly.
Byron Donalds filed the most $CMA purchases (3), and Byron Donalds the most sales (1).
Activity peaked in 2022 with 4 trades.
Members who trade CMA
Recent disclosed trades in CMA
| Date | Member | Type | Amount |
|---|---|---|---|
| Oct 6 | Rohit Khanna(CA) | buy | $1K–$15K |
| Oct 6 | Rohit Khanna(CA) | buy | $1K–$15K |
| Nov 15 | Rohit Khanna(CA) | buy | $1K–$15K |
| Apr 24 | Rohit Khanna(CA) | sell | $1K–$15K |
| Dec 7 | Byron Donalds(FL) | sell | $1K–$15K |
| Aug 12 | Byron Donalds(FL) | buy | $1K–$15K |
| Aug 12 | Byron Donalds(FL) | buy | $1K–$15K |
| May 3 | Byron Donalds(FL) | buy | $1K–$15K |
Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →